Reports
Reports
Sale
The global glycomics market attained a value of about USD 1.58 billion in 2023. The market is further expected to grow at a CAGR of 15.1% during the forecast period of 2024-2032 to reach nearly USD 5.58 billion by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The global market for glycomics is being driven by its various applications in drug discovery and diagnostics. The field of glycoscience is growing at a healthy pace owing to robust investments in glycomic and proteomic research. Glycans are found in all living organisms, and due to the rising number of chronic diseases, robust pharmaceutical investments in the research and development (R&D) for glycans to treat diseases like inflammatory and cardiometabolic disorders is boosting the growth of the market. In addition to this, academic and research institutes play a significant role in the growth of the market. This can be attributed to the growth and advancement of research institutions, active collaborations between pharmaceutical companies and research centres to study the relationship between glycan structure and different diseases. These factors are augmenting the market growth of glycomics.
Glycomics or glycobiology refers to the study of the structure, composition, and function of carbohydrates or glycans found in a living organism for the diagnosis of a disease or for the development of a cure.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
On the basis of product, the market can be divided into:
Enzymes can be further classified into glycosidases, neuraminidases, glycosyltransferases, and sialyltransferases, among others.
Kits can be sub-divided into glycan labelling kits, glycan purification kits, and glycan release kits, among others.
Reagents can be further segmented into glycoproteins, monosaccharides, and oligosaccharides, among others.
Instruments can be further categorised into mass spectrometers, HPLC, MALDI-TOF, and array systems, among others.
Based on application, the market can be categorised into:
The market, based on end-use, can be segmented into:
The EMR report looks into the regional markets of glycomics like North America, Latin America, the Asia Pacific, Europe, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The global market for glycomics is being aided by the increasing healthcare expenditures by governments of developed and developing nations in the field of biology. Glycans play a crucial role in biological processes such as cell interaction and are therefore significant for drug and vaccine developments. The market growth can also be linked to the adoption of advanced research tools such as data analytics using progressive digital technology like artificial intelligence. Furthermore, the strategies employed by leading industry players to expand operations in untapped and emerging economies is another factor bolstering the growth of the market. Moreover, the advent of deep sequencing technologies has led to major analytical advances in the field of glycomics in recent years, hence invigorating the growth of the market.
The report presents a detailed analysis of the following key players in the global glycomics market, looking into their capacity, market share, and latest developments like capacity expansions, plant turnabouts and mergers and acquisitions:
The comprehensive report looks at the micro and macro aspects of the industry. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of the Porter’s Five Forces Model.
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Product |
|
Breakup by Application |
|
Breakup by End Use |
|
Breakup by Region |
|
Market Dynamics |
|
Competitive Landscape |
|
Companies Covered |
|
Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Opportunities and Challenges in the Market
8 Global Glycomics Market Analysis
8.1 Key Industry Highlights
8.2 Global Glycomics Historical Market (2018-2023)
8.3 Global Glycomics Market Forecast (2024-2032)
8.4 Global Glycomics Market by Product
8.4.1 Enzymes
8.4.1.1 Historical Trend (2018-2023)
8.4.1.2 Forecast Trend (2024-2032)
8.4.1.3 Breakup by Type
8.4.1.3.1 Glycosidases
8.4.1.3.1.1 Historical Trend (2018-2023)
8.4.1.3.1.2 Forecast Trend (2024-2032)
8.4.1.3.2 Neuraminidases
8.4.1.3.2.1 Historical Trend (2018-2023)
8.4.1.3.2.2 Forecast Trend (2024-2032)
8.4.1.3.3 Glycosyltransferases
8.4.1.3.3.1 Historical Trend (2018-2023)
8.4.1.3.3.2 Forecast Trend (2024-2032)
8.4.1.3.4 Sialyltransferases
8.4.1.3.4.1 Historical Trend (2018-2023)
8.4.1.3.4.2 Forecast Trend (2024-2032)
8.4.1.3.5 Others
8.4.2 Kits
8.4.2.1 Historical Trend (2018-2023)
8.4.2.2 Forecast Trend (2024-2032)
8.4.2.3 Breakup by Type
8.4.2.3.1 Glycan Labelling Kits
8.4.2.3.1.1 Historical Trend (2018-2023)
8.4.2.3.1.2 Forecast Trend (2024-2032)
8.4.2.3.2 Glycan Purification Kits
8.4.2.3.2.1 Historical Trend (2018-2023)
8.4.2.3.2.2 Forecast Trend (2024-2032)
8.4.2.3.3 Glycan Release Kits
8.4.2.3.3.1 Historical Trend (2018-2023)
8.4.2.3.3.2 Forecast Trend (2024-2032)
8.4.2.4.4 Others
8.4.3 Reagents
8.4.3.1 Historical Trend (2018-2023)
8.4.3.2 Forecast Trend (2024-2032)
8.4.3.3 Breakup by Type
8.4.3.3.1 Glycoproteins
8.4.3.3.1.1 Historical Trend (2018-2023)
8.4.3.3.1.2 Forecast Trend (2024-2032)
8.4.3.3.2 Monosaccharides
8.4.3.3.2.1 Historical Trend (2018-2023)
8.4.3.3.2.2 Forecast Trend (2024-2032)
8.4.3.3.3 Oligosaccharides
8.4.3.3.3.1 Historical Trend (2018-2023)
8.4.3.3.3.2 Forecast Trend (2024-2032)
8.4.3.3.4 Others
8.4.4 Instruments
8.4.4.1 Historical Trend (2018-2023)
8.4.4.2 Forecast Trend (2024-2032)
8.4.4.3 Breakup by Type
8.4.4.3.1 Mass Spectrometers
8.4.4.3.1.1 Historical Trend (2018-2023)
8.4.4.3.1.2 Forecast Trend (2024-2032)
8.4.4.3.2 HPLC
8.4.4.3.2.1 Historical Trend (2018-2023)
8.4.4.3.2.2 Forecast Trend (2024-2032)
8.4.4.3.3 MALDI-TOF
8.4.4.3.3.1 Historical Trend (2018-2023)
8.4.4.3.3.2 Forecast Trend (2024-2032)
8.4.4.3.4 Array Systems
8.4.4.3.4.1 Historical Trend (2018-2023)
8.4.4.3.4.2 Forecast Trend (2024-2032)
8.4.4.3.5 Others
8.5 Global Glycomics Market by Application
8.5.1 Drug Discovery and Development
8.5.1.1 Historical Trend (2018-2023)
8.5.1.2 Forecast Trend (2024-2032)
8.5.2 Diagnostics
8.5.2.1 Historical Trend (2018-2023)
8.5.2.2 Forecast Trend (2024-2032)
8.5.3 Others
8.6 Global Glycomics Market by End-Use
8.6.1 Academic and Research Institutes
8.6.1.1 Historical Trend (2018-2023)
8.6.1.2 Forecast Trend (2024-2032)
8.6.2 Pharmaceutical and Biotechnology Companies
8.6.2.1 Historical Trend (2018-2023)
8.6.2.2 Forecast Trend (2024-2032)
8.6.3 Contract Research Organisations (CROs)
8.6.3.1 Historical Trend (2018-2023)
8.6.3.2 Forecast Trend (2024-2032)
8.7 Global Glycomics Market by Region
8.7.1 North America
8.7.2 Europe
8.7.3 Asia Pacific
8.7.4 Latin America
8.7.5 Middle East and Africa
9 Regional Analysis
9.1 North America
9.1.1 Historical Trend (2018-2023)
9.1.2 Forecast Trend (2024-2032)
9.1.3 Breakup by Country
9.1.3.1 United States of America
9.1.3.2 Canada
9.2 Europe
9.2.1 Historical Trend (2018-2023)
9.2.2 Forecast Trend (2024-2032)
9.2.3 Breakup by Country
9.2.3.1 United Kingdom
9.2.3.2 Germany
9.2.3.3 France
9.2.3.4 Italy
9.2.3.5 Others
9.3 Asia Pacific
9.3.1 Historical Trend (2018-2023)
9.3.2 Forecast Trend (2024-2032)
9.3.3 Breakup by Country
9.3.3.1 China
9.3.3.2 Japan
9.3.3.3 India
9.3.3.4 ASEAN
9.3.3.5 Australia
9.3.3.6 Others
9.4 Latin America
9.4.1 Historical Trend (2018-2023)
9.4.2 Forecast Trend (2024-2032)
9.4.3 Breakup by Country
9.4.3.1 Brazil
9.4.3.2 Argentina
9.4.3.3 Mexico
9.4.3.4 Others
9.5 Middle East and Africa
9.5.1 Historical Trend (2018-2023)
9.5.2 Forecast Trend (2024-2032)
9.5.3 Breakup by Country
9.5.3.1 Saudi Arabia
9.5.3.2 United Arab Emirates
9.5.3.3 Nigeria
9.5.3.4 South Africa
9.5.3.5 Others
10 Market Dynamics
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyer’s Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 Key Indicators for Demand
10.4 Key Indicators for Price
11 Value Chain Analysis
12 Competitive Landscape
12.1 Market Structure
12.2 Company Profiles
12.2.1 Merck KGaA
12.2.1.1 Company Overview
12.2.1.2 Product Portfolio
12.2.1.3 Demographic Reach and Achievements
12.2.1.4 Certifications
12.2.2 Thermo Fisher Scientific Inc.
12.2.2.1 Company Overview
12.2.2.2 Product Portfolio
12.2.2.3 Demographic Reach and Achievements
12.2.2.4 Certifications
12.2.3 Shimadzu Corporation
12.2.3.1 Company Overview
12.2.3.2 Product Portfolio
12.2.3.3 Demographic Reach and Achievements
12.2.3.4 Certifications
12.2.4 Agilent Technologies, Inc.
12.2.4.1 Company Overview
12.2.4.2 Product Portfolio
12.2.4.3 Demographic Reach and Achievements
12.2.4.4 Certifications
12.2.5 Takara Bio Inc.
12.2.5.1 Company Overview
12.2.5.2 Product Portfolio
12.2.5.3 Demographic Reach and Achievements
12.2.5.4 Certifications
12.2.6 Others
13 Key Trends and Developments in the Market
Additional Customisations Available
1 Manufacturing Process
1.1 Overview
1.2 Detailed Process Flow
1.3 Operation Involved
2 Project Requirement and Cost Analysis
2.1 Land, Location and Site Development
2.2 Construction
2.3 Plant Machinery
2.4 Cost of Raw Material
2.5 Packaging
2.6 Transportation
2.7 Utilities
2.8 Manpower
2.9 Other Capital Investment
List of Key Figures and Tables
1. Global Glycomics Market: Key Industry Highlights, 2018 and 2032
2. Global Glycomics Historical Market: Breakup by Product (USD Million), 2018-2023
3. Global Glycomics Market Forecast: Breakup by Product (USD Million), 2024-2032
4. Global Glycomics Historical Market: Breakup by Application (USD Million), 2018-2023
5. Global Glycomics Market Forecast: Breakup by Application (USD Million), 2024-2032
6. Global Glycomics Historical Market: Breakup by End-Use (USD Million), 2018-2023
7. Global Glycomics Market Forecast: Breakup by End-Use (USD Million), 2024-2032
8. Global Glycomics Historical Market: Breakup by Region (USD Million), 2018-2023
9. Global Glycomics Market Forecast: Breakup by Region (USD Million), 2024-2032
10. North America Glycomics Historical Market: Breakup by Country (USD Million), 2018-2023
11. North America Glycomics Market Forecast: Breakup by Country (USD Million), 2024-2032
12. Europe Glycomics Historical Market: Breakup by Country (USD Million), 2018-2023
13. Europe Glycomics Market Forecast: Breakup by Country (USD Million), 2024-2032
14. Asia Pacific Glycomics Historical Market: Breakup by Country (USD Million), 2018-2023
15. Asia Pacific Glycomics Market Forecast: Breakup by Country (USD Million), 2024-2032
16. Latin America Glycomics Historical Market: Breakup by Country (USD Million), 2018-2023
17. Latin America Glycomics Market Forecast: Breakup by Country (USD Million), 2024-2032
18. Middle East and Africa Glycomics Historical Market: Breakup by Country (USD Million), 2018-2023
19. Middle East and Africa Glycomics Market Forecast: Breakup by Country (USD Million), 2024-2032
20. Global Glycomics Market Structure
The global glycomics market attained a value of nearly USD 1.58 billion in 2023.
The market is projected to grow at a CAGR of 15.1% in the forecast period of 2024-2032.
The market is estimated to witness a healthy growth in the forecast period of 2024-2032 to reach about USD 5.58 billion by 2032.
The market is being driven by the increasing prevalence of underlying diseases and the resultant rise in investments for pharmaceutical research and development (R&D) for diagnosis and drug development.
The market growth can be associated with robust government investments into the healthcare sector of developing countries and the advancements in advanced research and analytical tools.
The major regional markets for glycomics are North America, Latin America, the Asia Pacific, Europe, and the Middle East and Africa.
The different products of glycomics are enzymes, kits, reagents, and instruments.
The significant applications of glycomics are drug discovery and development, and diagnostics, among others.
The major end-uses of glycomics are academic and research institutes, pharmaceutical and biotechnology companies, and contact research organisations (CROs).
The major players in the industry are Merck KGaA, Thermo Fisher Scientific Inc., Shimadzu Corporation, Agilent Technologies, Inc., and Takara Bio Inc., among others.
The global glycomics market attained a value of about USD 1.58 billion in 2023, driven by growing pharmaceutical research and development (R&D). Aided by the advent of advanced research and analytical tools, the market is expected to grow at a CAGR of 15.1% in the forecast period of 2024-2032 to reach nearly USD 5.58 billion by 2032.
EMR’s meticulous research methodology delves deep into the market covering the macro and micro aspects of the industry. Based on product, the market can be divided into enzymes, kits, reagents, and instruments. On the basis of application, the market can be segmented into drug discovery and development, and diagnostics, among others. The market, based on end-use, can be classified into academic and research institutes, pharmaceutical and biotechnology companies, and contact research organisations (CROs). The major regional markets for glycomics are North America, Latin America, the Asia Pacific, Europe, and the Middle East and Africa. The key players in the industry are Merck KGaA, Thermo Fisher Scientific Inc., Shimadzu Corporation, Agilent Technologies, Inc., and Takara Bio Inc., among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus providing their customers with market insights that are accurate, actionable and help them remain ahead of their competition.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.